40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany

Page created by Roland Smith
 
CONTINUE READING
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
40 Jahre Brustkrebsforschung auf höchstem Niveau
GABG-GBG 40 years of high level BREAST Cancer Research
Made in Germany

                                               Prof. Dr. Sibylle Loibl
                                        Chair of the German Breast Group
                                     Centre of Haematology and Oncology
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
History and Milestones of the German Breast Group
1981: Foundation of GABG e.V.                    2003: Foundation of GBG                           2008: Expansion in                    2015: Biobank 2.0
                                                 Forschungs GmbH                                   translational research
 Today the living founders of the GBG                                                                                                    Modernization of biobank with
  are honorary members of the group               by Prof. von Minckwitz                                                                  more than 40,000 samples
                                                  Group renamed as German Breast                                                         Surgical study (INSEMA)
                                                   Group (GBG)
                                                                          2005: Biomaterial bank at the Dept. of
                                                                          Pathology of the Charité                                                             Biobank in Marburg
                        1990s: Further
                        studies and new
                                                                          2005: Start of the first post-                 2011: Central pathology
                        regulations
                                                                          neoadjuvant study (NATAN)

  1981         1980s       1990s         2002       2003        2004         2005        2006            2008      2011        2014         2015        2017         2019        2021

                                                                                                                            2014: First global study
                                     2002: Launch of neoadjuvant                      2006: Establishment                    Penelope-B: launch of first
                                     study GeparTrio                                  MedCODES®                               global registration study with
                                                                                                                              patients from 4 continents
                                      2,358 participants                                                                     sponsored by GBG
                                      First large scale study sponsored                                                                                   2019: ONCOBIOME
                                       by GBG                   2004: First international GBG study in          2011: Responsify
            1980s: Initial studies and expansion              metastatic breast cancer (TBP) and ARO                                                        EU-framework program
                                                              criteria                                           First EU-framework program                 H2020 with both partners
             Merger of GABG with the study group of the
                                                                                                                  under scientific leadership of
              Bundesministerium für Forschung und
                                                                                                                  GBG (Prof. Loibl and Prof.
                                                                                                                                                        2018: 50,000th patient
              Technologie (BMFT)
                                                                                                                  Denkert)
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
Studienpatienten
60000

50000

40000

30000

20000

10000

    0
        1980   1985   1990   1995   2000   2005   2010   2015   2020
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
Der Vorstand der GABG
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
GABG I
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
GABG III

                               GABG III-B
       tamoxifen (2 years)
R      6 x CMF
       + tamoxifen (2 years)

                                            6 x CMF → tamoxifen (2 years)*
                                 R          6 x FEC → tamoxifen (2 years)*
                                            * in ER/PgR positive disease only   GABG III-C
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
GABG IV
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
ZEBRA Studie – die erste internationale Kooperation
                                                                                                           ER +ve                    x                   N=1189

                                                                                                           ER -ve                                                   x
                                                                                                                                                                N=304

Kaplan-Meier DFS: ER-ve                                                                                    Overall                                 x            N=1614

                                       1.0
                                                                                                 Zoladex             0.8           1.0                 1.25
                                       0.9
Proportion alive and free of disease

                                                                                                 CMF
                                       0.8                                                                      Zoladex    Region of equivalents       CMF
                                       0.7
                                                                                                                better                                 better
                                       0.6                                                                                                     Interaction test, p=0.0016
                                       0.5

                                       0.4

                                       0.3

                                       0.2

                                       0.1

                                       0.0
                                             0   1   2    3     4      5     6     7     8   9      10
                                                         Disease-free survival (years)
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
40 Jahre Brustkrebsforschung auf höchstem Niveau - GABG-GBG 40 years of high level BREAST Cancer Research Made in Germany
Wo war die GABG 2001
Studientreffen 2000 der GABG
Studienleitkommission
Neoadjuvante Therapie - die Anfänge
GEPARDO
          JCO 1999, JCO 2001
                                                                 The German
              JCO 2005, JCO 2001
                     JNCI 2008, JNCI 2008, JCO 2013                GeparD
                           JCO 2010; JCO 2010; Ann Oncol 2013
                                   NEJM 2012; Lancet Oncol 2012; Ann Oncol 2013

                                            Lancet Onc 2014; Annals Oncol 2019
                                                    Lancet Onc 2016; J Clin Oncol 2019

>15000                                                      Eur J Cancer 2019; SABCS 2019

                                                                     Annals Oncol 2019; ASCO 2021
patients                                                                      Annals Oncol 2020
since 1998                                                                               SABCS 2019
Bei der BIG 2003
2003 in St. Gallen
GBG 2006
Internationales Parket
2014
2015
SABCS 2019-Impressionen GBG Beteiligung
GBG Subboards 2020 & AGO-B Board 2020
 Neoadjuvant                                Operativ
  Blohmer, Denkert, Fasching, Hanusch,        Ataseven, Blohmer, Denkert, Gerber,
  Huober, Jackisch, Link, Loibl, Rhiem,       Golatta, Hahn, Heil, Krug, Kühn, Loibl
  Schneeweiss, Solbach, Untch
 Adjuvant                                   Translationale Forschung (TraFo)
                   Vielen Dank an alle für die
  Loibl, Marmé, Möbus, Reimer, Stickeler,
  Reinisch, Janni, Schmatloch, Schmidt,
                                              Denkert, Fasching, Karn, Loibl, Marmé,
                                              Müller, Schem, Stickeler, van
  Sinn, Untch      GUTE ZUSAMMENARBEIT        Mackelenbergh
 Palliativ
  Decker, Denkert, Loibl, Lübbe,             AGO-B
  Mundhenke, Müller, Schmidt, Thill           Fasching, Fehm, Jackisch, Janni, Kühn,
                                              Lück, Möbus, Müller, Rack, Schmidt,
                                              Schneeweiss, Stickeler, Thomssen,
                                              Untch u.a.
Collaborators and network
                              Network                                                                                     Cooperation partners

                                              Cooperating study groups and universities
Cooperating laboratories

                                                                                                                  Grupo Espanol de
                                                                                                                  Investigacion del
                                                                                                                  Cancer de Mama

                                                                                          Alliance for Clinical
                                                                                          Trials in Oncology

                                                                                                Latin American
                                                                                                 Cooperative
                                                                                                Oncology Group
Acknowledgements
                                   External Partners                                         GBG

                                                                               GBG Subboard Members
                                                                               GBG Team
                                                       Michael Untch
                                                       Peter Fasching
                       Carsten Denkert
Cooperating partners

                       Paul Jank
                       Wolfgang Schmidt

                                                                        GBG
                       Rita Schmutzler                                        Valentina Nekljudova
                       Kerstin Rhiem                                          Bärbel Felder
                       Eric Hahnen                                            Karsten Weber
Grüße aus
 Frankfurt
You can also read